Gemcitabine Monotherapy for Metastatic Breast Cancer After Anthracycline and Taxane Regimen

Clinical trial NCT00191269 · COMPLETED

Trial details

NCT number: NCT00191269
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2005-06-01
Primary completion: 2008-03-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.